Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.510
-0.040 (-1.57%)
At close: Jul 10, 2026, 4:00 PM EDT
2.533
+0.023 (0.90%)
After-hours: Jul 10, 2026, 6:13 PM EDT
Kiora Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
11.12M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 16.02M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 12.06K | -2.67M | -99.55% |
| Dec 31, 2019 | 2.69M | 1.03M | 62.54% |
| Dec 31, 2018 | 1.65M | 1.25M | 305.51% |
| Dec 31, 2017 | 407.52K | -261.74K | -39.11% |
| Dec 31, 2016 | 669.26K | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Traws Pharma | 2.73M |
| OSR Health | 2.63M |
| BioLineRx | 1.40M |
| CytoMed Therapeutics | 669.28K |
| Exicure | 500.00K |
| BioCardia | 3.00K |
KPRX News
- 8 days ago - Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium - Newsfile Corp
- 22 days ago - Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model - Newsfile Corp
- 24 days ago - Kiora Pharmaceuticals Slides: Corporate presentation - Filings
- 7 weeks ago - Kiora Pharmaceuticals files to sell 11.8M shares of common stock for holders - TheFly
- 7 weeks ago - Kiora Pharmaceuticals Registration statement: Registration filing - Filings
- 2 months ago - Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update - Newsfile Corp
- 2 months ago - Kiora Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 2 months ago - Kiora Pharmaceuticals Earnings release: Q1 2026 - Filings